Invivyd (IVVD) Cash from Operations (QoQ) (2021 - 2025)
Invivyd (IVVD) Cash from Operations (QoQ) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,785.82 Bn | 1,785.76 Bn | - |
| 2 | Akari Therapeutics | 979.03 Bn | 979.03 Bn | - |
| 3 | BeOne Medicines | 473.13 Bn | 468.34 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.67 Bn | 116.43 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.57 Bn | 62.81 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.00 Bn | 62.00 Bn | - |
| 7 | Argenx Se | 54.61 Bn | 49.42 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 37.99 Bn | 34.98 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.09 Bn | 36.09 Bn | - |
| 10 | Invivyd | 102.48 Mn | -124.21 Mn | 16.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -87.33% |
| Sep 30, 2025 | 37.97% |
| Jun 30, 2025 | 37.05% |
| Mar 31, 2025 | 43.82% |
| Dec 31, 2024 | 8.42% |
| Sep 30, 2024 | 1.28% |
| Jun 30, 2024 | 17.16% |
| Mar 31, 2024 | 15.24% |
| Dec 31, 2023 | -67.57% |
| Sep 30, 2023 | 5.45% |
| Jun 30, 2023 | 9.20% |
| Mar 31, 2023 | 13.13% |
| Dec 31, 2022 | 15.56% |
| Sep 30, 2022 | 2.18% |
| Jun 30, 2022 | 2.81% |
| Mar 31, 2022 | 19.35% |
| Dec 31, 2021 | -35.05% |
| Sep 30, 2021 | -61.49% |
| Jun 30, 2021 | -41.40% |